174 related articles for article (PubMed ID: 14767530)
21. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.
Deng J; Xia W; Hung MC
Oncogene; 1998 Oct; 17(17):2167-75. PubMed ID: 9811448
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice.
Fleshner N; Fair WR; Huryk R; Heston WD
J Urol; 1999 May; 161(5):1651-4. PubMed ID: 10210433
[TBL] [Abstract][Full Text] [Related]
24. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4.
Spillare EA; Okamoto A; Hagiwara K; Demetrick DJ; Serrano M; Beach D; Harris CC
Mol Carcinog; 1996 May; 16(1):53-60. PubMed ID: 8634094
[TBL] [Abstract][Full Text] [Related]
25. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
[TBL] [Abstract][Full Text] [Related]
26. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.
Sells SF; Wood DP; Joshi-Barve SS; Muthukumar S; Jacob RJ; Crist SA; Humphreys S; Rangnekar VM
Cell Growth Differ; 1994 Apr; 5(4):457-66. PubMed ID: 8043520
[TBL] [Abstract][Full Text] [Related]
27. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid.
Kudoh T; Ishidate T; Nakamura T; Toyoshima K; Akiyama T
Oncogene; 1996 Oct; 13(7):1431-9. PubMed ID: 8875981
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells.
Yang C; Cirielli C; Capogrossi MC; Passaniti A
Cancer Res; 1995 Oct; 55(19):4210-3. PubMed ID: 7671222
[TBL] [Abstract][Full Text] [Related]
29. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
Nasu Y; Timme TL; Yang G; Bangma CH; Li L; Ren C; Park SH; DeLeon M; Wang J; Thompson TC
Nat Med; 1998 Sep; 4(9):1062-4. PubMed ID: 9734401
[TBL] [Abstract][Full Text] [Related]
30. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
[TBL] [Abstract][Full Text] [Related]
31. Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.
Dorai T; Goluboff ET; Olsson CA; Buttyan R
Anticancer Res; 1997; 17(5A):3307-12. PubMed ID: 9413164
[TBL] [Abstract][Full Text] [Related]
32. Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo.
Beham AW; Sarkiss M; Brisbay S; Tu SM; von Eschenbach AC; McDonnell TJ
Int J Mol Med; 1998 Jun; 1(6):953-9. PubMed ID: 9852630
[TBL] [Abstract][Full Text] [Related]
33. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
[TBL] [Abstract][Full Text] [Related]
34. Quiescence in R3327-G rat prostate tumors after androgen ablation.
Pollack A; Joon DL; Wu CS; Sikes C; Hasegawa M; Terry NH; White RA; Zagars GK; Meistrich ML
Cancer Res; 1997 Jun; 57(12):2493-500. PubMed ID: 9192831
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model.
Guinan P; Shaw M; Mirochnik Y; Slobodskoy L; Ray V; Rubenstein M
Methods Find Exp Clin Pharmacol; 1998 Nov; 20(9):739-42. PubMed ID: 10022026
[TBL] [Abstract][Full Text] [Related]
36. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
Lu S; Tsai SY; Tsai MJ
Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
[TBL] [Abstract][Full Text] [Related]
38. ET-1 expression and growth inhibition of prostate cancer cells: a retinoid target with novel specificity.
Hsu JY; Pfahl M
Cancer Res; 1998 Nov; 58(21):4817-22. PubMed ID: 9809984
[TBL] [Abstract][Full Text] [Related]
39. Effect of Bcl-2 overexpression in human prostate cancer cells in vitro and in vivo.
Kajiwara T; Takeuchi T; Ueki T; Moriyama N; Ueki K; Kakizoe T; Kawabe K
Int J Urol; 1999 Oct; 6(10):520-5. PubMed ID: 10533903
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches.
Hsieh JT; Luo W; Song W; Wang Y; Kleinerman DI; Van NT; Lin SH
Cancer Res; 1995 Jan; 55(1):190-7. PubMed ID: 7805032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
